J. Carlos Vallejo Llamas-rekin lankidetzan egindako argitalpenak (6)

2021

  1. Assessment of the association between cytomegalovirus DNAemia and subsequent acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation: A multicenter study from the Spanish hematopoietic transplantation and cell therapy group

    Transplant Infectious Disease, Vol. 23, Núm. 4

2014

  1. Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation

    Haematologica, Vol. 99, Núm. 10, pp. 1632-1637

2011

  1. Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab

    Expert Review of Hematology, Vol. 4, Núm. 1, pp. 9-16

  2. Update on bacteraemia in oncology and hematology

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. SUPPL. 4, pp. 48-53

2008

  1. Update on pulmonary infections in patients with hematologic malignancies and hematopoietic stem cell recipients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. SUPPL. 3, pp. 58-71

2006

  1. Donor age and degree of HLA matching have a major impact on the outcome of unrelated donor haematopoietic cell transplantation for chronic myeloid leukaemia

    Bone Marrow Transplantation, Vol. 37, Núm. 1, pp. 33-40